Detrol and Cardiac output decreased - a phase IV clinical study of FDA data

Summary:

Cardiac output decreased is reported only by a few people who take Detrol.

The phase IV clinical study analyzes which people take Detrol and have Cardiac output decreased. It is created by eHealthMe based on reports of 27,771 people who have side effects while taking Detrol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

27,771 people reported to have side effects when taking Detrol.
Among them, 5 people (0.02%) have Cardiac output decreased.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,206 Detrol users for its effectiveness, alternative drugs and more.

What is Cardiac output decreased?

Cardiac output decreased is found to be associated with 676 drugs and 290 conditions by eHealthMe.

Number of Detrol and Cardiac output decreased reports submitted per year:

Could Detrol cause Cardiac output decreased?

Gender of people who have Cardiac output decreased when taking Detrol *:

female: 0.0 %
male: 100 %

Age of people who have Cardiac output decreased when taking Detrol *:

Common drugs people take besides Detrol *:

Common side effects people have besides Cardiac output decreased *:

Weight Decreased: 5 people, 100.00%
Enlarged Prostate: 5 people, 100.00%
Confusional State: 5 people, 100.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 100.00%
Cyst (a closed sac): 5 people, 100.00%
Deformity (disfigurement): 5 people, 100.00%
Dehydration (dryness resulting from the removal of water): 5 people, 100.00%
Depression: 5 people, 100.00%
Dilatation Ventricular: 5 people, 100.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 100.00%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 5 people, 100.00%
Inflammation: 5 people, 100.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 20.00%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Detrol and have Cardiac output decreased?

Check whether Cardiac output decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Cardiac output decreased and when was it recovered:

Cardiac output decreased in Detrol

Expand to all the drugs that have ingredients of tolterodine tartrate:

Cardiac output decreased and drugs with ingredients of tolterodine tartrate

Alternative drugs to, pros and cons of Detrol:

Detrol (28,206 reports)

Common Detrol side effects:

Drug ineffective: 3,748 reports
Headache (pain in head): 1,614 reports
Fatigue (feeling of tiredness): 1,533 reports
Constipation: 1,471 reports
Weakness: 1,326 reports
Pain: 1,267 reports

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cardiac output decreased treatments and more:

Cardiac output decreased (1,236 reports)

COVID vaccines that are related to Cardiac output decreased:

Common drugs associated with Cardiac output decreased:

Furosemide: 130 reports

All the drugs that are associated with Cardiac output decreased:

Cardiac output decreased (676 drugs)

All the conditions that are associated with Cardiac output decreased:

Cardiac output decreased (290 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Detrol) and Detrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.